Detection superiority of 7 T MRI protocol in patients with epilepsy and suspected focal cortical dysplasia by Colon, Albert et al.
ORIGINAL ARTICLE
Detection superiority of 7 T MRI protocol in patients
with epilepsy and suspected focal cortical dysplasia
A. J. Colon1,2,3 • M. J. P. van Osch2 • M. Buijs2 • J. v. d. Grond2 • P. Boon1,3 •
M. A. van Buchem2 • P. A. M. Hofman1
Received: 7 April 2016 / Accepted: 14 June 2016 / Published online: 8 July 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract In 11 adult patients with suspicion of Focal
cortical dysplasia (FCD) on 1.5 T (n = 1) or 3 T (n = 10)
magnetic resonance imaging (MRI), 7 T MRI was per-
formed. Visibility, extent, morphological features and
delineation were independently rated and subsequently
discussed by three observers. Additionally, head-to-head
comparisons with corresponding 3 T images were made in
the eight patients with a previous 3 T MRI and sustained
suspicion of FCD. Comparison with histopathology was
done in the five patients that underwent surgery. All
lesions, seen at 1.5 and 3 T, were also recognized on 7 T.
At 7 T FLAIR highlighted the FCD-like lesions best,
whereas T2 and T2* were deemed better suited to review
structure and extent of the lesion. Image quality with the
used 7 T MRI setup was higher than the quality with the
used 3 T MRI setup. In 2 out of 11 patients diagnosis
changed, in one after re-evaluation of the images, and in
the other based on histopathology. With the used 7 T MRI
setup, FCD-like lesions can be detected with more confi-
dence and detail as compared to lower field strength.
However, concordance between radiologic diagnosis and
final diagnosis seems to be lower than expected.
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Abbreviations
EEG Electro encephalography
FCD Focal cortical dysplasia
FLAIR Fluid attenuated inversion recovery
IR Inversion recovery
MRI Magnetic resonance imaging
PET Positron emission tomography
SWI Susceptibility weighted imaging
T Tesla
TE Echo time
TR Relaxation time
Introduction
20–40 % of epilepsy patients are drug resistant. In this
group resective surgery, if possible, is the treatment of
choice [1, 2]. Finding a lesion on magnetic resonance
imaging (MRI) is of clinical importance, as presence of a
lesion is associated with a higher chance of developing
drug resistant (refractory) epilepsy [3] and increased suc-
cess rate of surgery [4–6]. Sensitivity of MRI for brain
lesions partly depends on the system’s magnetic field
strength [7–12]. Higher field strength gives rise to higher
signal-to-noise ratio, which allows for higher anatomical
resolution and increased sensitivity for contrast mecha-
nisms such as those based on iron [13–18]. Most studies in
epilepsy patients have been performed using 1.5 and 3 T
MRI systems. MRI systems operating at a magnetic field
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strength of 7 T may have added value for epilepsy patients
[19] especially because they may have a higher sensitivity
for focal cortical dysplasia (FCD) and decrease the number
of MRI-occult FCDs. In surgical series, FCD is a common
pathologic finding with a reported presence in 8 % [20] to
53 % of the operated epileptic patients [21]. 20–30 % of
patients with postsurgical proven FCD were MRI-negative
[3, 22, 23]. No systematic comparison between 3 and 7 T
MRI appearance of FCD is available. On the other hand,
MRI diagnosis of FCD can be erroneous. FCD’s can be
hard to distinguish from gliomas, with a preference for
FCD on frontal locations or a lesser distinct high intensity
on T2 weighted images than in case of glioma [24].
The most frequently described MRI features of FCD
include: increased cortical thickness, blurred grey/white
matter junction, increased signal on T2, decreased signal
on T1 of the subcortical white matter and gyration
anomalies [22, 23]. The most typical feature highly specific
for FCD type II is alteration of white matter signal towards
the ventricle, the ‘‘transmantle sign’’ [25]. Presence of a
focal lesion (e.g., mesiotemporal sclerosis) combined with
FCD defines FCD type III. FCD can be characterised by
combinations of several of the above mentioned MRI
features [26]. In many patients only a subset of these MRI
features are detected [26]. As presentation of an abnor-
mality can be dependent on the field strength, we wanted to
study the presentation on 7 T MRI of FCD’s previously
described on lower field strength MRI. Further more find-
ings on 3 T MRI if available were compared to the
appearance at 7 T MRI and radiologic diagnosis was
compared to histopathology in operated cases.
Methods
Ten adult patients, diagnosed with localisation related
epilepsy and presence of a lesion diagnosed as FCD on 3 T
(n = 10) or 1.5 T (n = 1) MRI, were included (patient
characteristics: Table 1). An additional patient (patient 5)
was excluded from further analysis as due to technical
failure on 7 T MRI the signal-to-noise ratio was too low.
All lesions were located extra-temporal, one with temporal
extension and one with dual pathology. Standard MRI
exclusion criteria were applied. Presence of a dental
retainer wire was added as a 7 T-specific MRI exclusion
criterion. At present this is not an exclusion criterion any
more [27]. Informed consent was obtained from all indi-
vidual participants included in the study. The study was
approved by the Institutional Review Board of LUMC
(Leiden Universitair Medisch Centrum).
7 T MRI was performed on a Philips Achieva platform
(Philips Healthcare, Cleveland, Ohio) using a 32 channel
receive head coil with quadrature transmit. The following
sequences were used: 3D T1 (TR 4.2 ms, TE 1.88 ms,
voxel-size 0.9 9 0.9 9 0.9 mm), 3D FLAIR (TR
7900 ms, TE 300 ms, TI 2200 ms, voxel-size
0.85 9 0.85 9 0.85 mm), T2 TSE (TR 3000 ms, TE
58 ms, voxel-size 0.5 9 0.5 9 1 mm) and T2* (TR
1764 ms, TE 25 ms, voxel-size 0.24 9 0.24 9 1 mm).
Total acquisition time was under 1 h, which was consid-
ered acceptable for possible future use in clinical practice.
The 3 T MRI images were acquired using a 16 channel
receive head coil and a state-of-the-art epilepsy protocol
[3D-T1 (TR 8.1 ms, TE 3.7 ms, voxel 1 9 1 9 1 mm), T2
Table 1 Patient characteristics of patients with FCD-like lesion on prior MRI
Patient Age Sex Location of lesion on previous
MRI
Semiology
1 34 M Right frontal Conscious, forced head version to right followed by secondary generalisation
2 22 M Left parietal Short lasting: light headedness, goosebumps, staring, incorrect answers, bilateral
manual automatisms
3 25 V Left frontal Stretching right arm and inability to speak
4 44 M Left temporo-occipital Lowered consciousness, automatisms, wandering
5 47 M Left parietal Nightly symmetric or asymmetric tonic contractions or very brief myoclonias
6 21 M Right parietal Visual hallucinations, lowered consciousness, hypermotor behaviour
7 47 V Right hand knob Pounding sensation left thumb, painfull contraction left hand
8 20 M Left frontal (ganglioglioma)
and left parietal (FCD)
Sensation of mouth movement, inability to speak, problems with co-ordination. If
secondary generalisation then post-ictal visual disturbances
9 34 M Left parietal Vibrating sensation right face, sensation of falling to the right (actually going to the
left), raising right arm, staring. Fully conscious
10 36 V Left parietal 1. Sensation of jaw cramp, tingeling gums, hypersalivation, aphasia
2. Short epigastric aura, tonic contraction right arm, secondary generalisation
11 43 V Right frontal 1. Cephalic sensation, fear, sensation of short of breath
2. During sleep head turning to left, orofacial automatisms and/or bipedaling and/or
hypertonia left arm
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(TR 3000 ms, TE 80 ms, voxel 0.5 9 0.5 9 5 mm), T2*
in the last 5 patients (TR 777 ms, TE 16 ms, voxel
0.9x1.1x5 mm), IR (TR 120 ms, TE 10 ms, TI 400 ms,
voxel 0.4 9 0.6 9 2 mm), FLAIR (TR 8000 ms, TE
50 ms, TI 2400 ms, voxel 1.1 9 1.1 9 0.5 mm)] per-
formed on a Philips 3.0 T Achieva platform (Philips
Medical systems, Best, The Netherlands). Diagnosis of
FCD was made by an experienced neuroradiologist in a
tertiary epilepsy centre (PH). In one patient only 1.5 T
MRI, made in a referring hospital, was available; since this
1.5 T MRI examination showed clearly an FCD, additional
3 T MRI was deemed unnecessary.
Patient charts were examined by two neurologists (AC,
LW), with experience in analysing patients for epilepsy
surgery. Based on medical history, semiology, EEG, and if
available seizure-recordings clinical estimation of the
location of the epileptogenic focus was formulated. If the
patient underwent surgery data on histopathology were
noted. Data were compared to the MRI results.
Two experienced neuroradiologists (MvB, PH) and a
neurologist (AC) visually inspected the images.
All observers were aware of the presence of an MRI-
detectable lesion. Windowing was individually adapted to
gain optimal contrast. Orientation of slides with the highest
visibility of the abnormality was chosen separately for each
field strength. Presence and characteristics of a possible
FCD (see Table 2) were noted using a predefined scoring
system. Seven features were scored: blurring of the grey–
white matter junction, focal thickening of the cortex, focal
increased intensity, presence of a transmantle sign, clear
demarcation of transition to normal cortex, gyral pattern
and abnormal internal structure. A flag-like appearance of
the FCD was noted in several patients. This characteristic
was added to the study.
In eight patients with a 3 T MRI and a sustained pre-
operative diagnosis of FCD the features of the FCD on T2
and FLAIR images were rated for visibility using a Likert
scale from 1 to 3 [28]: 1 indicating 7 T superior to 3 T, 2
equal quality, and 3 indicating 3 T superior to 7 T.
Comparison was made between the same sequences using a
Sign test (http://www.fon.hum.uva.nl/Service/Statistics/
Sign_Test.html). Non-difference was set as the null
hypothesis. As T2* was not available in all 3 T MRIs no
comparison between T2* on 7 T and on 3 T sequence was
made.
Results
In none of the patients abnormalities were found on 7 T
MRI that were not observed at lower field strength and all
lesions visible at lower field strength were visible at 7 T. In
the ten analysed patients, both neurologists agreed that the
stereotyped seizures were based on a single epileptogenic
focus. In each patient one or more hypotheses on the
possible locations of this epileptogenic focus could be
postulated. Comparison between these hypotheses and the
location of the lesion on MRI showed concordance in each
individual patient.
By visual inspection in all patients the lesion was
detected on 7 T MRI without prior knowledge of the
Table 2 Features of FCD recognized on 7 T MRI, all sequences combined
Patient 2 3 4 6 7 8 9 10 11 Overall
Blurring ? ? ? ? ? ? ? ? ? 9/9
Focal thickening ? ? ? ? - ? ? ? ? 8/9
Focal increased intensity ? ? ? ? ? ? ? ? ? 9/9
Transmantle sign - ? - - ? ? ? ? ? 6/9
Transition to normal cortex v s s s v s s s s 2 vague, 7 sharp
Gyral pattern norm abn abn abn norm norm abn abn abn 6/9
Abnormal internal structure ? ? ? ? ? ? ? ? ? 9/9
Total 4/7 7/7 6/7 6/7 4/7 6/7 7/7 7/7 7/7
? present, - not visible, v vague, s scharp, norm normal, abn abnormal
Fig. 1 7 T T1 image showing cortical thickening and blurring
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location as seen at lower field strength. In patient 1 the
diagnosis changed from FCD to cavernoma based on the
7 T MRI and re-evaluation of the 3 T images. The treating
physician was informed. Further visual analysis of the 7 T
MRI was done for the remaining nine patients.
On the T1-weighted images cortical thickening and
blurring were most prominent (Fig. 1). A hypo-intense line
at the grey–white matter junction was observed on T2
weighted images (Fig. 2) in eight patients creating a typical
three layer flag-like appearance. Detection of the FCD was
readily made on the FLAIR images (Fig. 3), whereas the
abnormal internal structure of FCDs was most clearly seen
on T2* (Fig. 4). Supplementary online data shows more
examples. Of the seven imaging features, four (blurring of
grey–white matter, focal signal increase, visibility of tran-
sition to normal cortex, abnormal internal structure) were
observed in all nine patients. Focal thickening was observed
in eight patients, funnel shaped extension in and the pres-
ence of an abnormal gyral pattern in six patients (Table 2).
The flag-like appearance was noted in all but patient 3.
In the eight patients in whom 3 T MRI was available,
7 T MRI depiction scored significantly better than 3 T
MRI for blurring (p\ 0.01), abnormalities of internal
structure (p\ 0.01) and demarcation of transition to nor-
mal cortex (p\ 0.02) (Fig. 5) on T2 and for abnormalities
of internal structure (p\ 0.04) on FLAIR. Although not
statistically significant, 7 T MRI tended to be superior to
3 T on another 7 out of 14 scored items (2 sequences
compared, with 7 features analysed in each comparison)
3 T MRI tended to be superior to 7 T on none of the 14
items (Table 3). When combining all seven analysed
characteristics on T2 and FLAIR in each individual patient,
7 T scored better than 3 T (Table 4).
Five of the six included patients that were also evaluated
for epilepsy surgery were operated. In patient 3
histopathology showed a ganglioglioma WHO grade 1,
patient 8 had FCD type IIIb (frontal infantile desmoplastic
ganglioglioma with bordering FCD operated plus parietal
FCD that we analysed in this study), patient 9 showed a
FCD type IIa and patients 10 and 11 showed a FCD type
IIb. The location of the lesion was congruent between MRI
and surgical specimen. The 3 and 7 T MRI images of the
Fig. 2 7 T T2 image showing
cortical thickning, transmantle
sign (left) and flag-like
appearence at the bottom of the
sulcus in FCD (right more
pronounced than left)
Fig. 3 7 T FLAIR image, showing highlighted FCD
262 Acta Neurol Belg (2016) 116:259–269
123
two patients in whom the diagnosis changed from FCD to,
respectively cavernoma and ganglioglioma are shown in
Fig. 6.
One patient complained of profound nausea at entering
the MRI. Slowing down the table movement reduced the
symptoms. During the imaging this complaint was not
present.
Discussion
The main finding of this study is that all observers agreed
that on conventional visual analysis the lesions were easily
detected and better detailed with the applied 7 T MRI
protocol than on lower field strength. None of the known
lesions were missed on the 7 T images. Using a semi-
quantitative scale, overall our 7 T MRI protocol tended to
be superior to the previously applied 3 T protocol. Statis-
tical significance was reached for 4 out of 14 scored items.
In two patients final diagnosis changed from FCD to,
respectively cavernoma and gangioglioma.
As far as we know this is the first publication describing
7 T MRI in a group of patients with suspicion of FCD
using a standard clinical protocol.
In one patient, due to the 7 T images diagnosis changed
from FCD to cavernoma. There are several explanations
Fig. 4 7 T T2* image showing abnormal internal structure of FCD
Fig. 5 Comparison between 3 (top) and 7 (bottom) T images of a patient with known FCD right hand knob to deep-of-the-sulcus. From left to
right T2, FLAIR
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possible for this change. First, due to slice thickness in the
3 T images the small hemosiderin deposit could have been
located exactly in between two slices, thus escaping
detection. Due to the thinner slice thickness of the 7 T
images, the hemosiderin is more obvious. The images as
depicted in Fig. 6 seem to substantiate this hypothesis.
Second, the artefact effect of hemosiderin is more pro-
nounced on 7 T MRI than on 3 T MRI, thereby high-
lighting the cavernoma more evidently in 7 T MRI. The
sequence most sensitive for hemosiderin is SWI
Table 3 Conventional visual
analysis of 3 vs 7 T images
Blue 7 T superior to 3 T, red 7 T and 3 T equal, green 3 T superior to 7 T, purple feature not visible, Last
column p-values Sign Test, significant values in fat
Table 4 Comparison between 3 and 7 T MRI’s combining all characteristic on T2 and FLAIR
Patient 2 3 4 6 7 8 10 11 7 T better:3 T better
Blurring T2 1 1 1 1 1 1 1 1 8/8:0/8
Focal thickening T2 Na 0 1 1 Na 1 1 0 4/6:0/6 (na:2)
Focal increased intensity T2 1 0 1 1 1 0 0 -1 4/8:1/8
Transmantle sign T2 Na 0 Na Na Na 0 1 1 2/4:0/4 (na:4)
Transition to normal cortex T2 1 1 1 1 1 1 1 0 7/8:0/8
Gyral pattern T2 Na Na 1 1 Na Na Na Na 2/2 (na:6)
Internal structure T2 1 1 1 1 1 1 1 1 8/8:0/8
Blurring FLAIR -1 0 1 1 1 1 1 1 6/8:1/8
Focal thickening FLAIR Na 0 1 1 Na 1 0 0 3/6:0/6 (na:2)
Focal increased intensity FLAIR -1 0 1 1 1 1 1 0 5/8:1/8
Transmantle sign FLAIR Na 1 Na Na 0 0 1 1 3/5:0/5 (na:3)
Transition to normal cortex FLAIR -1 1 1 1 1 1 1 W 7 T, G 3 T (1) 6a/8:1a/8
Gyral pattern FLAIR Na Na 1 1 Na Na Na Na 2/2:0/2 (na:6)
Internal structure FLAIR Na Na 1 1 1 1 1 1 6/6:0/6 (na:2)
Total 7 T better than 3 T 4/7 5/11 12/12 12/12 8/9 9/12 10/12 6/11a
Total 3 T better than 7 T 3/7 0/11 0/12 0/12 0/9 0/12 0/12 1/11a
Total not applicable 7 3 2 2 5 2 2 2a
-1 3 T better than 7 T, 0 equally visible on 3 T and 7 T, 1 7 T better than 3 T, Na Not applicable as not visible on either 7 T or 3 T, W white
matter, G gray matter
a Excluding patient 11 transition to normal cortex on FLAIR
264 Acta Neurol Belg (2016) 116:259–269
123
(susceptibility weighted imaging). However, in epilepsy
the presence of small hemosiderin deposits is of minor
relevance and therefore in the initial phase of our study this
sequence was not part of our standard epilepsy protocol.
This will have probably lowered the sensitivity for the
detection of small haemorrhages of the 3 T MRI more than
the sensitivity of 7 T MRI. Especially compared to 7 T
MRI in which a T2* weighted sequence was part of the
protocol. Third, there is a time delay of several months
between these 3 and 7 T MRI’s. Although there were no
additional clinical symptoms, it is possible that in between
these time points the amount of blood surrounding the
Fig. 6 3 and 7 T MRI images of the two patients with changed diagnosis. Each sequence contrasted and angulated individually
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cavernoma increased. As the patient is no longer under our
care we regrettably do not have access to a 3 T MRI made
after the 7 T MRI.
In one of the five operated cases histopathology showed
that the abnormality was a ganglioglioma instead of a FCD
type II as the radiological diagnosis stated. Re-challenging
of three pathologists and two radiologists with information
on the opinion of the other specialist did not change their
conclusions. Taking the diagnosis of the pathologists as
golden standard, this proves that MRI can help giving an
Fig. 6 continued
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indication of the diagnosis. But visual inspection is not
(yet) able to provide the definite diagnosis with 100 %
certainty. Noteworthy is the fact that in this patient (patient
3) all evaluated MRI-characteristics of FCD were present.
The frequency of the imaging features of FCDs as seen
in our study is higher than reported for FCD in the litera-
ture for 1.5 and 3 T studies. For example cortical thick-
ening was seen in 50 % [29] to 76 % [30] whereas in our
series it is 89 %. Blurring ranged from 36 % [31] to 87 %
[32], whereas in our series it is 100 %. For transmantle sign
this ranged from 19 % [33] to 81 % [31], and in our series
it is 67 %. Most publications are based on histopathologi-
cally proven diagnoses of FCD, including patients without
MRI abnormalities, whereas for our study the suspicion of
a FCD on lower field strength MRI was an inclusion cri-
terion. This explains the relative high frequency of the
imaging features in our series. Quality of the 7 T MRI
images itself plays a role as well: signal-to-noise ratio
scales approximately linear with magnetic field strength
[34, 35]. Furthermore, it has also been observed that 7 T
MRI provides an increased contrast-to-noise ratio in
FLAIR as compared to 1.5 and 3 T [13, 36]. The smaller
voxels that can be achieved with 7 T MRI within a clini-
cally applicable protocol will also provide better spatial
resolution, leading to the detection of thin abnormalities,
such as blurring or the transmantle sign.
Other limitations of the current studies include the fact
that, besides the magnetic field strength, the scanners dif-
fered with respect to other hardware such as the number of
receive channels of the head-coil and that choices of
sequence parameters were based on local expertise without
an effort to homogenize these between the field strengths.
Comparisons were made between acquisitions made on the
scanners available to us, which led to inherent differences
in receive and transmit coil properties, other hardware
components as well as software. Using, for example, a
32-channel head coil for the 3 T might have improved
image quality on that field strength. However, based on our
experience with both field strengths we think that magnetic
field strength is the main contributor to the observed
improved image quality.
Applying visual analysis, in our series 7 T MRI FLAIR
was the sequence on which the lesions were most promi-
nent. The flag-like three-layer appearance is easiest
appreciated on T2. The middle hypo-intense line is
accentuated by the bordering hyper-intense parts of the
lesions. However, even though much less pronounced,
looking at the homologue contralateral area this line often
is bilaterally noticeable. The appearance of this line is not
equally distributed in all different regions, which is in line
with the findings of Zwanenburg et al. [37] who described
similar regional differences (but no asymmetries) in the
normal brain in 7 T MRI. The line is located at the grey–
white matter junction and is present in almost all regions,
and therefore it does not represent the striae of Gennari
[38]. Based on our small series, this line seems to be more
prominent with rising age, even more in the FCD-like
region than in the other regions of the brain. We postulate
that this line represents iron deposits which would explain
an age-dependency [39]. Alternatively, this line could
represent a low signal coming from the deepest cortical
layer, seen on thin 7 T slices but masked on thicker 3 T
slices. In 7 T MRI this accentuated three-layer appearance
on the T2 weighted images has the potential to be used as
an imaging marker of FCD. The internal structure and
extend of the lesions were best visible on T2 and especially
T2* sequences. This is in line with expectations, as the T2*
sequence provides high spatial resolution and sensitivity to
the magnetic susceptibility properties of tissues, thus
improving evaluation of the different components within
the cortex. When in more cases histopathology will become
available, this might help in differentiating between dif-
ferent pathological substrates, like the different types of
FCD.
Although due to the nature of this study we did not co-
register all the sequences of 3 and 7 T study, visual
inspection and interpretation support the notion that on 7 T
the lesion seemed often to extend beyond what is seen on
3 T.
Because of the better delineation of lesions on 7 T, if
intracranial EEG recording is needed we would advise to
use the T2 sequence to guide the implantation. Especially
in case of multiple depth-electrodes (stereo-EEG) where
presurgical delineation of the abnormality is even more
dependant on electrode placing than when using grids.
In epilepsy, abnormalities observed on MRI do not
always reflect the epileptogenic focus. This is illustrated by
the observation of Salmenpera et al. [40] that 9 % of 3 T
MRI-positive findings are not related to the epileptogenic
lesion. Therefore, every positive MRI result should be
interpreted with caution and in combination with the
electro clinical findings. However, clinical assessment
based on the intra-individual stereotyped semiology makes
it likely that all our patients had a single epileptogenic
focus, correlating well with the observed location of the
lesion. Interpretation of MRI should only be done including
all clinical information available. This holds true for all
other modalities such as PET, MEG and intracranial EEG
as well. Probably, multimodality fusion will increase
insight in analysing difficult surgery cases. The limitation
of our study is that we included only patients with a
diagnosis of FCD based on 3 or 1.5 T MRI and only three
patients had a histologically proven diagnosis. Further
studies will evaluate the additional value of 7 T MRI in
presurgical analysis in patients without abnormalities on
3 T MRI. There is one study on the detectability of FCD’s
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on 7 T MRI in 21 patients without lesions on 3 or 1.5 T
MRI, showing a 29 % diagnostic gain [41]. Agreement in
imaging interpretation was reached through consensus-
based discussions based on visual identification of struc-
tural abnormalities. Four out of the six patients with a thus
detected lesion were operated, all showing a FCD on
histopathology. These results are almost identical to our
own results [42].
Conclusion
7 T brain imaging in vivo is feasible in epilepsy patients and
can be beneficial. Lesions are well recognizable and details
are better visible than at lower field strengths. The presence
of typical FCD-characteristics on MRI; however, does not
always reflect the final histopathological diagnosis.
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